Autologous blood use in percutaneous nephrolithotomy

Urology

Volumn 54, Issue 3, 1999, Pages 444-449

  Stoller, Marshall L ^a,b   Lee, Keith L ^a   Schwartz, Bradley F ^a   Viele, Maurene K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; COST; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; NEPHROLITHOTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SURGICAL TECHNIQUE; UNITED STATES;

ADOLESCENT; ADULT; AGED; BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHROSTOMY, PERCUTANEOUS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 0032839661     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00164-8     Document Type: Article

References (26)

1. Pinkerton PH, and Klotz LH: Transfusion practice in urological surgery: modifications in association with the introduction of an autologous blood donor programme. Transfus Med 5: 69-73, 1995.
2. Noldus J, Gonnermann D, and Huland H: Autologous blood transfusion in radical prostatectomy: results in 263 patients. Eur Urol 27: 213-217, 1995.
3. State of California, Paul Gann Blood Safety Act. Health and Safety Code, Section 1645, January 1, 1990.
4. Chamberland M, and Khabbaz RF: Emerging issues in blood safety. Infect Dis Clin North Am 12: 217-229, 1998.
5. Wallace EL, Churchill WH, Surgenor DM, et al: Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 35: 802-812, 1995.
6. Popovsky MA, Whitaker B, and Arnold NL: Severe outcomes of allogenic and autologous blood donation: frequency and characterization. Transfusion 35: 734-737, 1995.
7. Schreiber GB, Busch MP, Kleinman SH, et al: The risk of transfusion-transmitted viral infections. N Engl J Med 334: 1685-1690, 1996.
8. Kanter MH, van Maanen D, Anders KH, et al: Preoperative autologous blood donations before elective hysterectomy. JAMA 276: 798-801, 1996.
9. Clugston PA, Fitzpatrick DG, Kester DA, et al: Autologous blood use in reduction mammaplasty: is it justified? Plast Reconstr Surg 95: 824-828, 1995.
10. Birkmeyer JD, AuBuchon JP, Littenberg B, et al: Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg 57: 161-168, 1994.
11. Goodnough LT, Grishaber JE, Birkmeyer JD, et al: Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology 44: 226-231, 1994.
12. Goh M, Kleer CG, Kielczewski P, et al: Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary? Urology 49: 569-573, 1997.
13. de Andrade JR: Prudent strategies for red blood cell conservation in orthopedic surgery. Am J Med 101(suppl 2A): 16S-21S, 1996.
14. Monk TG, Goodnough LT, Birkmeyer JD, et al: Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy. Transfusion 35: 559-565, 1995.
15. Monk TG, Goodnough LT, Brecher ME, et al: Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg 85: 953-958, 1997.
16. Lee SJ, Neumann PJ, Churchill WH, et al: Patients' willingness to pay for autologous blood donation. Health Policy 40: 1-3, 1997.
17. Ferguson KJ, Strauss RG, Toy PT, and the Preoperative Autologous Blood Donation Study Group: Physician recommendation as the key factor in patient's decisions to participate in preoperative autologous blood donation programs. Am J Surg 168: 2-5, 1994.
18. Goodnough LT, and Monk TG: Evolving concepts in autologous blood procurement and transfusion: case reports of perisurgical anemia complicated by myocardial infraction. Am J Med 101(suppl 2A): 33S-37S, 1996.
19. Stoller ML, Wolf JS, and St Lezin MA: Estimated blood loss and transfusion rates associated with percutaneous nephrolithotomy. J Urol 152: 1977-1981, 1994.
20. Davidoff R, and Bellman GC: Influence of technique of percutaneous tract creation on incidence of renal hemorrhage. J Urol 157: 1229-1231, 1997.
21. Goldman M, Remy-Prince S, Trepanier A, et al: Autologous donation error rates in Canada. Transfusion 37: 523-527, 1997.
22. Taswell HF, Galbreath JL, and Harmsen WS: Errors in transfusion medicine: detection, analysis, frequency, and prevention. Arch Pathol Lab Med 118: 405-410, 1994.
23. Domen RE: Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospital. Transfusion 38: 296-300, 1998.
24. Fletcher H, Frederick J, Hardie M, et al: A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol 87: 1014-1018, 1996.
25. Chun TY, Martin S, and Lepor H: Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy. Urology 50: 727-732, 1997.
26. Price TH, Goodnough LT, Vogler WR, et al: Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin. Am J Med 101(suppl 2A): 22S-27S, 1996.